Effect of multiple injections of U-50,488H, a κ-opioid receptor agonist, on the activity of nitric oxide synthase in brain regions and spinal cord of mice

General Pharmacology

Volumn 29, Issue 3, 1997, Pages 397-399

  Bhargava, Hemendra N ^a   Kumar, Shailendra ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

opioid receptor agonist; 488H; 3H arginine; 3H citrulline; Brain regions; Mice; Nitric oxide synthase; Spinal cord; U 50

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; KAPPA OPIATE RECEPTOR; NITRIC OXIDE SYNTHASE; OPIATE AGONIST;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DRUG TOLERANCE; DRUG WITHDRAWAL; ENZYME ACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESENCEPHALON; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANIMALS; BRAIN; INJECTIONS, SPINAL; MALE; MICE; NITRIC OXIDE SYNTHASE; PAIN MEASUREMENT; RECEPTORS, OPIOID, KAPPA; SPINAL CORD; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030818375     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00480-6     Document Type: Article

References (19)

1. Barjavel M. J. and Bhargava H. N. (1994) Effect of opioid receptor agonists on nitric oxide synthase activity in rat cerebral cortex homogenate. Neurosci. Letts. 181, 27-30.
2. Bhargava H. N. (1994a) Diversity of agents which modify opioid tolerance, physical dependence, abstinence syndrome and self-administrative behavior. Pharmac. Rev. 46, 293-324.
3. Bhargava H. N. (1994b) Nitric oxide synthase inhibitor blocks tolerance to the analgesic action of κ-opiate receptor agonists in the rat. Pharmacology 48, 234-241.
4. Bhargava H. N. (1995) Attenuation of tolerance to and physical dependence on morphine in the rat by inhibition of nitric oxide synthase. Gen. Pharmac. 26, 1049-1053.
5. 2-opioid receptor agonist in mice. Brain Res. 719, 56-61.
6. Bredt D. S. and Snyder S. H. (1992) Nitric oxide, a novel neuronal messenger. Neuron 8, 3-11.
7. D'Amour F. E. and Smith D. L. (1941) A method for determining loss of pain sensation. J. Pharmac. Exp. Ther. 72, 74-79.
8. Garthwaite J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14, 60-67.
9. Johnson S. M. and Fleming W. W. (1989) Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence. Pharmac. Rev. 41, 435-488.
10. Knowles R., Palacios M., Palmer R. M. J. and Moncada S. (1989) Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 86, 5159-5162.
11. Kolesnikov Y. A., Pick C.G., Ciszesska G. and Pasternak G. W. (1993) Blockade of tolerance to morphine but not to κ-opioid by nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. USA 90, 5162-5166.
12. G-Nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmac. 221, 399-400.
13. Kumar S. and Bhargava H. N. (1997) Time-course of the changes in central nitric oxide synthase activity following chronic treatment with morphine in the mouse: reversal by naltrexone. Gen. Pharmac. (in press).
14. Leza J. C., Lizasoain I., San-Martin-Clark O. and Lorenzo P. (1995) Morphine-induced changes in cerebral and cerebellar nitric oxide synthase activity. Eur. J. Pharmac. 285, 95-98.
15. Lowry O. H., Rosebrough N.J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
16. Moncada S., Palmer R. M. J. and Higgs E. A. (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pnarmac. Rev. 43, 109-142.
17. Schmidt H. H. H. W., Wilke P., Evers B. and Bohme E. (1989) Enzymatic formation of nitric oxide from L-arginine in bovine brain cytosol. Biochem. Biophys. Res. Commun. 165, 284-291.
18. Thorat S. N., Reddy P. L. and Bhargava H. N. (1993) Evidence for the role of nitric oxide in kappa opiate tolerance in mice. Brain Res. 621, 171-174.
19. 1,-opioid receptor agonist. Peptides 17, 233-236.